Barcelona, Spain (September 8, 2025, Noon CEST / UTC +2 ) — BMS-986504, a first-in-class methylthioadenosine (MTA)-cooperative protein arginine methyltransferase 5 (PRMT5) targeting agent, showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback